Darwin Bioprospecting Excellence
Darwin Bioprospecting Excellence is a Spanish biotechnology firm that selects and supplies microbial strains for the biotechnology industry, supported by genomics-based characterization and a small scientific team based in Paterna.
- Company typePrivate
- Founded2016
- HeadquartersPaterna, Spain
- Headcount11–50
- GTM typeB2B
- OfferingServices
What Darwin Bioprospecting Excellence does
Darwin Bioprospecting Excellence is a privately held Spanish biotechnology firm, founded in 2016 and headquartered in Paterna, Spain, that selects microbial strains for the biotechnology industry. The company is structured as a small team of 11–50 employees and operates with a scientific orientation: a Scientific Director (Javier Pascual) and a Head of Genomics (Adriel Latorre Pérez) suggest that strain isolation, characterization, and genomic analysis form the technical core of its work.
Underlying capabilities appear to combine classical microbiology (environmental sampling, strain isolation) with genomics-based characterization, producing a proprietary catalog of microbial strains and associated sequence/functional data intended for industrial biotech buyers. The leadership bench also includes a CEO (Manuel Porcar Miralles), a COO (Cristina Vilanova Serrador), a Marketing & Strategy Director (Daniel Ramón Calvo), a Business Development Director (Paula Álvarez Ameijeiras), and a Head of Public Funding (Kristie Tanner), indicating a build-out toward commercial sales and non-dilutive grant capture.
The business model is consistent with an early-stage services / strain-library supplier: revenue mechanics are not publicly disclosed, no pricing or contract value signals are available, and no named customers or revenue figures have been reported. The company's only recorded external capital event is a February 2025 financing backed by Biozell Ventures and Repsol Energy Ventures, suggesting recent activation of commercial scaling efforts. Customer segments, geographic markets served, and productized offerings are not documented in the available source material, which limits further factual specification.
Darwin Bioprospecting Excellence firmographics
Firmographics- Name
- Darwin Bioprospecting Excellence
- Website
- https://darwinbioprospecting.com
- Company type
- Private
- Founded year
- 2016
- Headcount range
- 11–50 employees
- Short description
- Darwin Bioprospecting Excellence is a Spanish biotechnology firm that selects and supplies microbial strains for the biotechnology industry, supported by genomics-based characterization and a small scientific team based in Paterna.
- Ownership category
- akta.pro rank
Darwin Bioprospecting Excellence industry classification
Industry- Product category
- Microbial Bioprospecting Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Microbiome Analytics, Sequencing & Bioinformatics Platforms (HLAAAFAI)
- akta.pro secondary industry
- Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery) (HLAAAFAJ)
Keywords
Where Darwin Bioprospecting Excellence is headquartered
LocationHeadquarters
- HQ city
- Paterna
- HQ country
- Spain
- HQ region
- Europe
Markets served
Darwin Bioprospecting Excellence business model
Business model- GTM type
- B2B
- Offering type
- Services
- Cost components
- Personnel, Technology or R&D, Operations, Marketing or Sales
Darwin Bioprospecting Excellence product offering
Product offeringCore offering
Darwin Bioprospecting Excellence isolates, characterizes, and selects microbial strains for use in industrial biotechnology applications. The company supplies curated microbial isolates and associated genomic information to biotechnology clients developing products in areas such as energy, bioproducts, and bio-based processes. Services include screening and selection of microorganisms from natural environments for research, development, and industrial use.
Differentiator
Problem solved
Functional benefit
Products and services
- Microbial Strain Selection for Biotechnology
Companies that use Darwin Bioprospecting Excellence
Customer profileIdeal customer profiles1 record
Darwin Bioprospecting Excellence technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Darwin Bioprospecting Excellence partnerships and signals
Strategic signalRecent moves2 records
Expansion highlights3 records
Darwin Bioprospecting Excellence competitors and assessment
Company assessmentDirect peers
- Ginkgo Bioworks: U.S.-based synthetic biology platform that engineers and screens microbial strains for industrial customers. Directly comparable to Darwin in providing outsourced microbial strain selection and characterization services for the biotechnology industry, though at vastly larger scale.
- Culture Biosciences: Cloud fermentation and microbial process development services for biotech R&D. Comparable to Darwin as a services partner that supports industrial customers with microbial strain work, screening and bioprocess development.
- LanzaTech: Develops proprietary microbial platforms (acetogen strains) for gas fermentation and industrial biotech applications. Comparable in that it selects and engineers microbial strains for industrial biotechnology customers, including in the energy space relevant to Darwin's Repsol-led investor base.
Broad incumbents
- Novonesis (formerly Novozymes): Global leader in industrial enzymes and microbial solutions across food, beverage, agriculture and energy. While vastly larger and more vertically integrated, it overlaps with Darwin's microbial selection activity for biotech customers and is a likely end-customer and competitive reference point.
- dsm-firmenich: Large science-based company with substantial industrial biotech, enzyme and microbial product lines. Comparable as a broad incumbent that both uses microbial strains internally and competes for outsourced discovery work.
- AB Enzymes: Industrial enzyme manufacturer that screens and selects microbial strains for enzyme production. Comparable to Darwin as a buyer and developer of microbial strains, though operating at commercial manufacturing scale rather than as a discovery services firm.
- bioMérieux: Global in vitro diagnostics and industrial microbiology company with extensive microbial culture and strain libraries. Comparable as a broader industrial microbiology incumbent whose microbial collection and identification capabilities overlap with Darwin's strain-selection offerings.
Emerging players
- Bota Bio: Synthetic biology company that engineers microbial strains for sustainable biomanufacturing of chemicals and ingredients. Comparable to Darwin as a specialist firm offering microbial strain capabilities to industrial biotech customers, though focused on engineered rather than naturally isolated strains.
Regional players
- BioCat (Microbiological Reference Cultures): European microbiology-focused distributor and reference-culture supplier. Comparable to Darwin as a European player in the microbial strain/reference materials space, primarily serving regional biotech customers.
Others
- ATCC (American Type Culture Collection): Non-profit biological resource center distributing authenticated microbial strains and reference materials to the biotechnology industry. Comparable to Darwin as a foundational source of microbial strains for industrial biotech and academic customers, though operating as a non-profit repository rather than a discovery services firm.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat3 records
Key risks4 records
Key highlights5 records
Customer concentration
Darwin Bioprospecting Excellence social profiles
Digital presenceDarwin Bioprospecting Excellence financial estimates
Financial estimateRevenue estimate
Valuation estimate
Darwin Bioprospecting Excellence leadership team
Management profileNumber of profiles
Profiles8 records
Darwin Bioprospecting Excellence funding detail
Funding detailFunding overview
Funding rounds1 record
Investors2 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Darwin Bioprospecting Excellence M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Darwin Bioprospecting Excellence
What does Darwin Bioprospecting Excellence do?
Darwin Bioprospecting Excellence isolates, characterizes, and selects microbial strains for use in industrial biotechnology applications. The company supplies curated microbial isolates and associated genomic information to biotechnology clients developing products in areas such as energy, bioproducts, and bio-based processes. Services include screening and selection of microorganisms from natural environments for research, development, and industrial use.
When was Darwin Bioprospecting Excellence founded?
Darwin Bioprospecting Excellence was founded in 2016. It employs 11 to 50 people.
Where is Darwin Bioprospecting Excellence based?
Darwin Bioprospecting Excellence is headquartered in Paterna, Spain, in the Europe region.
Who are Darwin Bioprospecting Excellence's main competitors?
Direct peers on record are Ginkgo Bioworks, Culture Biosciences and LanzaTech. Broad incumbents are Novonesis (formerly Novozymes), dsm-firmenich, AB Enzymes and bioMérieux. Bota Bio is listed as an emerging player. BioCat (Microbiological Reference Cultures) is listed as a regional player. ATCC (American Type Culture Collection) is listed as an others.
Does Darwin Bioprospecting Excellence have an API?
No public API is recorded for Darwin Bioprospecting Excellence.
What industry is Darwin Bioprospecting Excellence in?
Darwin Bioprospecting Excellence's product category is Microbial Bioprospecting Services. Its primary akta.pro industry code is HLAAAFAI, Microbiome Analytics, Sequencing & Bioinformatics Platforms, with a secondary code of HLAAAFAJ, Microbiome Manufacturing, Formulation & Delivery Technologies (encapsulation, spores, oral delivery). Its NAICS code is 541714 and its SIC code is 8731.